Research source
AI helped find CKAP2 as a strong new marker to spot bladder cancer in tissue samples.
Based on Multi-omics integration and clinical validation identify CKAP2 as a diagnostic biomarker for bladder cancer.
Published by World journal of surgical oncologyJun 23, 2026
Peer-reviewed paperHigh evidenceHuman study
What researchers observed
This study used multi-omics and clinical tests to show CKAP2 as a diagnostic biomarker for bladder cancer.
What this could mean
This could help researchers better detect bladder cancer by focusing on CKAP2, which may improve early identification and study of the disease if validated further.
What researchers still need to learn
Researchers still need to learn whether CKAP2-based detection improves patient outcomes or treatment success in larger studies.